In Plain Sight
ASH19 in Orlando, FL
Orlando: In the second of our ASH19 reports, we offer a comprehensive and in-depth look at important data presented over the weekend where we breakdown some of the key findings or trial readouts, which are likely of interest to many readers given the heightened attention on novel therapeutic approaches.
Whether the hematologic malignancy is myeloma, leukemia, or lymphoma, we have been rather spoiled for choice in selections for hot topics to discuss this year, so the series will likely run all week!
Here’s the second of our detailed ASH notes…
To learn more from our latest oncology conference insights and get a heads up on our latest ASH Coverage, subscribers can log-in or you can click to gain access to BSB Premium Content.
This content is restricted to subscribers
